 | • レポートコード：GIR-203B16299 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 血漿由来医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の血漿由来医薬品の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の血漿由来医薬品の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 血漿由来医薬品市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・免疫グロブリン、凝固因子濃縮物、その他 用途別セグメントは次のように区分されます。 ・救急医療、エピデミック疾患、免疫系障害、抗体欠乏症、凝固障害、その他 世界の血漿由来医薬品市場の主要な市場プレーヤーは以下のとおりです。 ・Novartis(CSL Limited)、Biotest AG (Creat Group Corporation)、Grifols SA、Sigma-Aldrich、Thermo Fisher Scientific、Octapharma AG、Takeda、Kedrion、China Biologic Products、LFB Group 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、血漿由来医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な血漿由来医薬品メーカーの企業概要、2019年～2021年までの血漿由来医薬品の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な血漿由来医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別血漿由来医薬品の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの血漿由来医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での血漿由来医薬品市場予測を収録しています。 ・第12、13、14章では、血漿由来医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Novartis(CSL Limited)、Biotest AG (Creat Group Corporation)、Grifols SA、Sigma-Aldrich、Thermo Fisher Scientific、Octapharma AG、Takeda、Kedrion、China Biologic Products、LFB Group ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：免疫グロブリン、凝固因子濃縮物、その他 ・用途別分析2016年-2026年：救急医療、エピデミック疾患、免疫系障害、抗体欠乏症、凝固障害、その他 ・血漿由来医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・血漿由来医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・血漿由来医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血漿由来医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・血漿由来医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Plasma-derived Medicinal Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Plasma-derived Medicinal Products size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Plasma-derived Medicinal Products market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Plasma-derived Medicinal Products market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunoglobulins
Coagulation Factor Concentrates
Other
Market segment by Application can be divided into
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others
The key market players for global Plasma-derived Medicinal Products market are listed below:
Novartis(CSL Limited)
Biotest AG (Creat Group Corporation)
Grifols SA
Sigma-Aldrich
Thermo Fisher Scientific
Octapharma AG
Takeda
Kedrion
China Biologic Products
LFB Group
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Plasma-derived Medicinal Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma-derived Medicinal Products, with price, sales, revenue and global market share of Plasma-derived Medicinal Products from 2019 to 2021.
Chapter 3, the Plasma-derived Medicinal Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma-derived Medicinal Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Plasma-derived Medicinal Products market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Plasma-derived Medicinal Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Plasma-derived Medicinal Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma-derived Medicinal Products Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Immunoglobulins
1.2.3 Coagulation Factor Concentrates
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma-derived Medicinal Products Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Emergency Care
1.3.3 Epidemic Diseasae
1.3.4 Immune System Disorder
1.3.5 Antibody Deficiency
1.3.6 Coagulation Disorder
1.3.7 Others
1.4 Global Plasma-derived Medicinal Products Market Size & Forecast
1.4.1 Global Plasma-derived Medicinal Products Sales in Value (2016-2026))
1.4.2 Global Plasma-derived Medicinal Products Sales in Volume (2016-2026)
1.4.3 Global Plasma-derived Medicinal Products Price by Type (2016-2026) & (US$/Unit)
1.5 Global Plasma-derived Medicinal Products Production Capacity Analysis
1.5.1 Global Plasma-derived Medicinal Products Total Production Capacity (2016-2026)
1.5.2 Global Plasma-derived Medicinal Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma-derived Medicinal Products Market Drivers
1.6.2 Plasma-derived Medicinal Products Market Restraints
1.6.3 Plasma-derived Medicinal Products Trends Analysis
2 Manufacturers Profiles
2.1 Novartis(CSL Limited)
2.1.1 Novartis(CSL Limited) Details
2.1.2 Novartis(CSL Limited) Major Business
2.1.3 Novartis(CSL Limited) Plasma-derived Medicinal Products Product and Services
2.1.4 Novartis(CSL Limited) Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Biotest AG (Creat Group Corporation)
2.2.1 Biotest AG (Creat Group Corporation) Details
2.2.2 Biotest AG (Creat Group Corporation) Major Business
2.2.3 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product and Services
2.2.4 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Grifols SA
2.3.1 Grifols SA Details
2.3.2 Grifols SA Major Business
2.3.3 Grifols SA Plasma-derived Medicinal Products Product and Services
2.3.4 Grifols SA Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sigma-Aldrich
2.4.1 Sigma-Aldrich Details
2.4.2 Sigma-Aldrich Major Business
2.4.3 Sigma-Aldrich Plasma-derived Medicinal Products Product and Services
2.4.4 Sigma-Aldrich Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Plasma-derived Medicinal Products Product and Services
2.5.4 Thermo Fisher Scientific Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Octapharma AG
2.6.1 Octapharma AG Details
2.6.2 Octapharma AG Major Business
2.6.3 Octapharma AG Plasma-derived Medicinal Products Product and Services
2.6.4 Octapharma AG Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Plasma-derived Medicinal Products Product and Services
2.7.4 Takeda Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Kedrion
2.8.1 Kedrion Details
2.8.2 Kedrion Major Business
2.8.3 Kedrion Plasma-derived Medicinal Products Product and Services
2.8.4 Kedrion Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 China Biologic Products
2.9.1 China Biologic Products Details
2.9.2 China Biologic Products Major Business
2.9.3 China Biologic Products Plasma-derived Medicinal Products Product and Services
2.9.4 China Biologic Products Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 LFB Group
2.10.1 LFB Group Details
2.10.2 LFB Group Major Business
2.10.3 LFB Group Plasma-derived Medicinal Products Product and Services
2.10.4 LFB Group Plasma-derived Medicinal Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Plasma-derived Medicinal Products Sales by Manufacturer
3.1 Global Plasma-derived Medicinal Products Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Plasma-derived Medicinal Products Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Plasma-derived Medicinal Products
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma-derived Medicinal Products Manufacturer Market Share
3.4.2 Top 6 Plasma-derived Medicinal Products Manufacturer Market Share
3.5 Global Plasma-derived Medicinal Products Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Plasma-derived Medicinal Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma-derived Medicinal Products Market Size by Region
4.1.1 Global Plasma-derived Medicinal Products Sales in Volume by Region (2016-2026)
4.1.2 Global Plasma-derived Medicinal Products Revenue by Region (2016-2026)
4.2 North America Plasma-derived Medicinal Products Revenue (2016-2026)
4.3 Europe Plasma-derived Medicinal Products Revenue (2016-2026)
4.4 Asia-Pacific Plasma-derived Medicinal Products Revenue (2016-2026)
4.5 South America Plasma-derived Medicinal Products Revenue (2016-2026)
4.6 Middle East and Africa Plasma-derived Medicinal Products Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Plasma-derived Medicinal Products Sales in Volume by Type (2016-2026)
5.2 Global Plasma-derived Medicinal Products Revenue by Type (2016-2026)
5.3 Global Plasma-derived Medicinal Products Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Plasma-derived Medicinal Products Sales in Volume by Application (2016-2026)
6.2 Global Plasma-derived Medicinal Products Revenue by Application (2016-2026)
6.3 Global Plasma-derived Medicinal Products Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Plasma-derived Medicinal Products Sales by Type (2016-2026)
7.2 North America Plasma-derived Medicinal Products Sales by Application (2016-2026)
7.3 North America Plasma-derived Medicinal Products Market Size by Country
7.3.1 North America Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
7.3.2 North America Plasma-derived Medicinal Products Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma-derived Medicinal Products Sales by Type (2016-2026)
8.2 Europe Plasma-derived Medicinal Products Sales by Application (2016-2026)
8.3 Europe Plasma-derived Medicinal Products Market Size by Country
8.3.1 Europe Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
8.3.2 Europe Plasma-derived Medicinal Products Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Plasma-derived Medicinal Products Sales by Type (2016-2026)
9.2 Asia-Pacific Plasma-derived Medicinal Products Sales by Application (2016-2026)
9.3 Asia-Pacific Plasma-derived Medicinal Products Market Size by Region
9.3.1 Asia-Pacific Plasma-derived Medicinal Products Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Plasma-derived Medicinal Products Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Plasma-derived Medicinal Products Sales by Type (2016-2026)
10.2 South America Plasma-derived Medicinal Products Sales by Application (2016-2026)
10.3 South America Plasma-derived Medicinal Products Market Size by Country
10.3.1 South America Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
10.3.2 South America Plasma-derived Medicinal Products Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2016-2026)
11.2 Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2016-2026)
11.3 Middle East & Africa Plasma-derived Medicinal Products Market Size by Country
11.3.1 Middle East & Africa Plasma-derived Medicinal Products Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Plasma-derived Medicinal Products Typical Distributors
12.3 Plasma-derived Medicinal Products Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Plasma-derived Medicinal Products Revenue by Type, (USD Million), 2021-2026
Table 2. Global Plasma-derived Medicinal Products Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis(CSL Limited) Basic Information, Manufacturing Base and Competitors
Table 4. Novartis(CSL Limited) Major Business
Table 5. Novartis(CSL Limited) Plasma-derived Medicinal Products Product and Services
Table 6. Novartis(CSL Limited) Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biotest AG (Creat Group Corporation) Basic Information, Manufacturing Base and Competitors
Table 8. Biotest AG (Creat Group Corporation) Major Business
Table 9. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product and Services
Table 10. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Grifols SA Basic Information, Manufacturing Base and Competitors
Table 12. Grifols SA Major Business
Table 13. Grifols SA Plasma-derived Medicinal Products Product and Services
Table 14. Grifols SA Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 16. Sigma-Aldrich Major Business
Table 17. Sigma-Aldrich Plasma-derived Medicinal Products Product and Services
Table 18. Sigma-Aldrich Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 20. Thermo Fisher Scientific Major Business
Table 21. Thermo Fisher Scientific Plasma-derived Medicinal Products Product and Services
Table 22. Thermo Fisher Scientific Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Octapharma AG Basic Information, Manufacturing Base and Competitors
Table 24. Octapharma AG Major Business
Table 25. Octapharma AG Plasma-derived Medicinal Products Product and Services
Table 26. Octapharma AG Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Takeda Basic Information, Manufacturing Base and Competitors
Table 28. Takeda Major Business
Table 29. Takeda Plasma-derived Medicinal Products Product and Services
Table 30. Takeda Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Kedrion Basic Information, Manufacturing Base and Competitors
Table 32. Kedrion Major Business
Table 33. Kedrion Plasma-derived Medicinal Products Product and Services
Table 34. Kedrion Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. China Biologic Products Basic Information, Manufacturing Base and Competitors
Table 36. China Biologic Products Major Business
Table 37. China Biologic Products Plasma-derived Medicinal Products Product and Services
Table 38. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. LFB Group Basic Information, Manufacturing Base and Competitors
Table 40. LFB Group Major Business
Table 41. LFB Group Plasma-derived Medicinal Products Product and Services
Table 42. LFB Group Plasma-derived Medicinal Products Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Plasma-derived Medicinal Products Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Plasma-derived Medicinal Products Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Plasma-derived Medicinal Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Plasma-derived Medicinal Products Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Plasma-derived Medicinal Products Production Site of Key Manufacturer
Table 48. Plasma-derived Medicinal Products New Entrant and Capacity Expansion Plans
Table 49. Plasma-derived Medicinal Products Mergers & Acquisitions in the Past Five Years
Table 50. Global Plasma-derived Medicinal Products Sales by Region (2016-2021e) & (K Units)
Table 51. Global Plasma-derived Medicinal Products Sales by Region (2021-2026) & (K Units)
Table 52. Global Plasma-derived Medicinal Products Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Plasma-derived Medicinal Products Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
Table 55. Global Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
Table 56. Global Plasma-derived Medicinal Products Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Plasma-derived Medicinal Products Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Plasma-derived Medicinal Products Price by Type (2016-2021e) & (US$/Unit)
Table 59. Global Plasma-derived Medicinal Products Price by Type (2021-2026) & (US$/Unit)
Table 60. Global Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
Table 61. Global Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
Table 62. Global Plasma-derived Medicinal Products Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Plasma-derived Medicinal Products Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Plasma-derived Medicinal Products Price by Application (2016-2021e) & (US$/Unit)
Table 65. Global Plasma-derived Medicinal Products Price by Application (2021-2026) & (US$/Unit)
Table 66. North America Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
Table 67. North America Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
Table 68. North America Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
Table 71. North America Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
Table 72. North America Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
Table 73. North America Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
Table 74. Europe Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
Table 76. Europe Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
Table 80. Europe Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Plasma-derived Medicinal Products Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Plasma-derived Medicinal Products Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Plasma-derived Medicinal Products Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Plasma-derived Medicinal Products Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
Table 90. South America Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
Table 91. South America Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
Table 92. South America Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
Table 95. South America Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
Table 96. South America Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
Table 97. South America Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Plasma-derived Medicinal Products Typical Distributors
Table 109. Plasma-derived Medicinal Products Typical Customers
List of Figures
Figure 1. Plasma-derived Medicinal Products Picture
Figure 2. Global Plasma-derived Medicinal Products Sales Market Share by Type in 2020
Figure 3. Immunoglobulins
Figure 4. Coagulation Factor Concentrates
Figure 5. Other
Figure 6. Global Plasma-derived Medicinal Products Sales Market Share by Application in 2020
Figure 7. Emergency Care
Figure 8. Epidemic Diseasae
Figure 9. Immune System Disorder
Figure 10. Antibody Deficiency
Figure 11. Coagulation Disorder
Figure 12. Others
Figure 13. Global Plasma-derived Medicinal Products Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Plasma-derived Medicinal Products Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Plasma-derived Medicinal Products Sales (2016-2026) & (K Units)
Figure 16. Global Plasma-derived Medicinal Products Price by Type (2016-2026) & (US$/Unit)
Figure 17. Global Plasma-derived Medicinal Products Production Capacity (2016-2026) & (K Units)
Figure 18. Global Plasma-derived Medicinal Products Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Plasma-derived Medicinal Products Market Drivers
Figure 20. Plasma-derived Medicinal Products Market Restraints
Figure 21. Plasma-derived Medicinal Products Market Trends
Figure 22. Global Plasma-derived Medicinal Products Sales Market Share by Manufacturer in 2020
Figure 23. Global Plasma-derived Medicinal Products Revenue Market Share by Manufacturer in 2020
Figure 24. Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Plasma-derived Medicinal Products Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Plasma-derived Medicinal Products Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Plasma-derived Medicinal Products Sales Market Share by Region (2016-2026)
Figure 28. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2016-2026)
Figure 29. North America Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
Figure 30. Europe Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
Figure 32. South America Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Plasma-derived Medicinal Products Revenue (2016-2026) & (USD Million)
Figure 34. Global Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
Figure 35. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2026)
Figure 36. Global Plasma-derived Medicinal Products Price by Type (2016-2026) & (US$/Unit)
Figure 37. Global Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
Figure 38. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2026)
Figure 39. Global Plasma-derived Medicinal Products Price by Application (2016-2026) & (US$/Unit)
Figure 40. North America Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
Figure 41. North America Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
Figure 42. North America Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
Figure 43. North America Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
Figure 44. United States Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
Figure 48. Europe Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
Figure 49. Europe Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
Figure 50. Europe Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
Figure 51. Germany Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Plasma-derived Medicinal Products Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Plasma-derived Medicinal Products Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Plasma-derived Medicinal Products Revenue Market Share by Region (2016-2026)
Figure 60. China Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
Figure 67. South America Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
Figure 68. South America Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
Figure 69. South America Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Plasma-derived Medicinal Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
薬用シャンプーのグローバル市場 2021年：企業別、地域別、種類・用途別 The Medicinal Shampoo market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …- 植物由来甘味料のグローバル市場 2021年：企業別、地域別、種類・用途別 The Plant-derived Sweetener market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 放電プラズマ焼結（SPS）製造システムのグローバル市場 2021年：企業別、地域別、種類・用途別 The Spark Plasma Sintering Manufacturing System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- プラズマドライエッチングシステムのグローバル市場 2021年：企業別、地域別、種類・用途別 The Plasma Dry Etch System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 低圧プラズマシステムのグローバル市場 2021年：企業別、地域別、種類・用途別 The Low Pressure Plasma System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…